Inventor · disambiguated record
Mark T. Dupriest
Also filed as: DUPRIEST MARK T
8 granted patents·2 pending applications·92 citations·filing 1984–2009
86Inventor score
Top patents by PatentIndex Score
10 records- 0191US4755528AHigh energy ionizing protective 2,3-diamino-1,4-butanedithiol; 4,5-diamino-1,2-dithiane; and N-acyl and N-alkyl derivatives thereof, compositions and method of use thereforALCON LAB INC·Filed 1987·Granted Jul 5, 1988·36 cites·13 claims
- 0282US4659733AMethod for treating hypertension with 2,3-diamino-1,4-butanedithiol; 4,5-diamino-1,2-dithiane; and N-acyl and N-alkyl derivatives thereofALCON LAB INC·Filed 1984·Granted Apr 21, 1987·14 cites·7 claims
- 0375US5612364ASubstantially pure apraclonidineALCON LAB INC·Filed 1995·Granted Mar 18, 1997·18 cites·4 claims
- 0451US2010152676A1Drug Loading Through PlungerALCON RES LTD·Filed 2009·Application pending·0 cites
- 0546US5177105AMethods for controlling intraocular pressure with transition metal complexesALCON LAB INC·Filed 1992·Granted Jan 5, 1993·14 cites·4 claims
- 0646US2010160870A1Two Piece Housing For Drug LoadingALCON RES LTD·Filed 2009·Application pending·0 cites
- 0744US5151544AIntermediates in the preparation of chiral spirofluorenehydantoinsALCON LAB INC·Filed 1990·Granted Sep 29, 1992·2 cites·8 claims
- 0835US5030651AMethods and compositions for controlling, preventing and treating oxidative insult in the eye with transition metal complexesALCON LAB INC·Filed 1989·Granted Jul 9, 1991·6 cites·12 claims
- 0930US5356932AMethods and compositions for controlling intraocular pressure with transition metal complexesALCON LAB INC·Filed 1993·Granted Oct 18, 1994·2 cites·12 claims
- 1023US4968809ASpirofluoreneisothiazolidinone dioxides as aldose reductase inhibitorsDUPRIEST MARK T·Filed 1988·Granted Nov 6, 1990·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Mark T. Dupriest files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →